Quick Answer
Pharma-Bio Serv, Inc. reported Total Assets of $13.65 million for the year ending 2025.
- Pharma-Bio Serv, Inc. showed a decrease of -16.2% in Total Assets from 2024 to 2025.
- This data is from Pharma-Bio Serv, Inc.'s annual report (Form 10-K), filed with the SEC on January 29, 2026.
- XBRL data for this metric is available from 2010 to 2025 (16 years of filings). Earlier data may not exist in machine-readable XBRL format as companies adopted electronic filing at different times.
- Quarterly values from 10-Q filings: Q3 2011: $9.48 million | Q1 2012: $11.47 million | Q2 2012: $12.51 million | Q3 2012: $13.92 million | Q1 2013: $16.40 million | Q2 2013: $18.03 million | Q3 2013: $19.11 million | Q1 2014: $21.08 million | Q2 2014: $21.61 million | Q3 2014: $22.03 million | Q1 2015: $22.95 million | Q2 2015: $23.09 million | Q3 2015: $23.31 million | Q1 2016: $23.84 million | Q2 2016: $24.21 million | Q1 2017: $23.06 million | Q2 2017: $22.56 million | Q3 2017: $22.51 million | Q1 2018: $22.41 million | Q2 2018: $22.51 million | Q3 2018: $23.31 million | Q1 2019: $25.28 million | Q2 2019: $25.65 million | Q3 2019: $26.25 million | Q1 2020: $26.16 million | Q2 2020: $28.64 million | Q3 2020: $30.10 million | Q1 2021: $30.20 million | Q2 2021: $27.90 million | Q3 2021: $28.59 million | Q1 2022: $22.07 million | Q2 2022: $20.16 million | Q3 2022: $20.33 million | Q1 2023: $20.90 million | Q2 2023: $19.62 million | Q3 2023: $20.30 million | Q1 2024: $19.23 million | Q2 2024: $16.92 million | Q3 2024: $16.32 million | Q1 2025: $16.08 million | Q2 2025: $13.90 million | Q3 2025: $13.59 million | Q4 2025: $13.65 million | Q1 2026: $13.55 million.
- Over the full 16 years of available data (2010 to 2025), Pharma-Bio Serv, Inc.'s Total Assets has grown by 108.2%.
- Historical annual values: Fiscal year 2025: $13.65 million | Fiscal year 2024: $16.29 million | Fiscal year 2023: $19.90 million | Fiscal year 2022: $20.65 million | Fiscal year 2021: $23.92 million | Fiscal year 2020: $29.92 million | Fiscal year 2019: $26.63 million | Fiscal year 2018: $25.38 million | Fiscal year 2017: $22.35 million | Fiscal year 2016: $24.00 million | Fiscal year 2015: $24.14 million | Fiscal year 2014: $23.21 million | Fiscal year 2013: $21.28 million | Fiscal year 2012: $15.74 million | Fiscal year 2011: $10.85 million | Fiscal year 2010: $6.56 million.
- Data sourced from SEC EDGAR public filings as of August 5, 2026.
Last verified: